Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
Top Cited Papers
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9247), 2031-2036
- https://doi.org/10.1016/s0140-6736(00)03399-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?Trends in Pharmacological Sciences, 1996
- The Neuropsychiatric InventoryNeurology, 1994
- Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimerʼs diseaseNeuroReport, 1994
- Lewy bodies and response to tacrine in Alzheimer's diseaseThe Lancet, 1994
- Neuroleptic sensitivity in patients with senile dementia of Lewy body type.BMJ, 1992
- Interrater Reliability of Extrapyramidal Signs in a Group Assessed for DementiaArchives of Neurology, 1991
- The cognitive drug research computerized assessment system for demented patients: A validation studyInternational Journal of Geriatric Psychiatry, 1991
- Senile dementia of Lewy body typeJournal of the Neurological Sciences, 1990
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975
- ParkinsonismNeurology, 1967